SANTA FE, NM--Molecular Informatics Inc., a bioinformatics software company here, has signed a deal with Genzyme Corp. to license Molecular Informatics's BioMerge software to enhance and support the Multiple Allele-Specific Diagnostic Assay (MASDA) and Serial Analysis of Gene Expression (SAGE) products offered by two Genzyme subsidiaries.
BioMerge combines object-oriented and relational database technologies in an enterprise-wide software system used to process, manage, integrate, and analyze genomic information. The agreement also gives Genzyme early access to Molecular Informatics technology, consulting, and product services.
MASDA is used to analyze multiple patient DNA samples for hundreds of mutations on one or more genes at the same time. SAGE is a genomics tool that detects and quantitates gene expression levels in different tissues. BioMerge will help compare the genetic data generated by MASDA and SAGE to that in public genomic databases.